The California Israel Chamber of Commerce (CICC) is a not-for-profit, industry-supported organization dedicated to promoting and strengthening thought leadership, business, investment, entrepreneurship, technology and trade relations between the business communities of California and Israel. With its wide and dynamic network of over 10,000 entrepreneurs, companies, business executives, investors and service providers, CICC provides a networking platform for joint venture programs between the two communities.

Through networking events, personalized introductions, mentorship programs, investment forums, roundtables, educational seminars and delegations, CICC contributes to a stronger business and commercial alliance between California and Israel.

The California Israel Chamber of Commerce (CICC) is a platform for global corporations and investors to connect with leading Israeli tech companies through personalized introductions, networking events, forums and delegations.  

CICC has partnered with Silicon Valley and global giants such as Intel, Google, Facebook, Cisco, Oracle, Microsoft, EMC, PayPal, SAP, Samsung, to name a few.  

Current areas of focus are MedTech; Big Data, SaaS & Cloud; Cyber Security; Mobile & Internet; and AgTech. 

CICC contributes to stronger commercial ties between Silicon Valley, Israel and global companies. 

“For a young start up that is taking its first steps in the US market it is very comforting to know that you have carrying “parents” in the form of CIMED mentors that guides, connects and helps in those fragile first steps of unknown terrain.”
Oded Cohen,
Founder and CEO,
“Congratulations and many thanks for a very well planned and run event at the CiMED 2016. The speakers and panels were highly professional and provided valuable insight. The meetings with the investors were very useful and opened multiple new opportunities. Combining the CiMED event with the tours, and the UCSF and WSGR conferences was perfect! Thanks a lot for making it a great success! “
Moshe Sarfaty,
Founder and CEO,
 LS Biopath